724 filings
REVOKED
IMNPQ
Immune Pharmaceuticals Inc
18 Aug 22
Registration or securities revoked
12:00am
8-K
IMNPQ
Immune Pharmaceuticals Inc
13 Apr 21
Completion of Acquisition or Disposition of Assets
8:50am
8-K
IMNPQ
Immune Pharmaceuticals Inc
12 Apr 21
Departure of Directors or Certain Officers
8:07am
4
Anthony S. Fiorino
4 Feb 20
IMMUNE PHARMACEUTICALS / Anthony S. Fiorino ownership change
11:45am
SC 13G
Hughes Eric Olan
12 Aug 19
Immune Pharmaceuticals Inc
10:04am
8-K
IMNPQ
Immune Pharmaceuticals Inc
8 Mar 19
Bankruptcy or Receivership
4:36pm
8-K
IMNPQ
Immune Pharmaceuticals Inc
14 Feb 19
Triggering Events That Accelerate or Increase a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement
12:00am
424B4
IMNPQ
Immune Pharmaceuticals Inc
7 Feb 19
Prospectus supplement with pricing info
4:18pm
S-1/A
IMNPQ
Immune Pharmaceuticals Inc
IPO registration (amended)
17 Jan 19
1:58pm
25-NSE
IMNPQ
Immune Pharmaceuticals Inc
8 Jan 19
Exchange delisting
10:15am
S-1/A
IMNPQ
Immune Pharmaceuticals Inc
IPO registration (amended)
19 Dec 18
5:31pm
8-K
IMNPQ
Immune Pharmaceuticals Inc
19 Dec 18
Amendments to Articles of Incorporation or Bylaws
4:26pm
8-K
IMNPQ
Immune Pharmaceuticals Inc
6 Dec 18
Immune Pharmaceuticals Announces Adjournment of Special Meeting of Stockholders
9:54am
DEFA14A
IMNPQ
Immune Pharmaceuticals Inc
6 Dec 18
Additional proxy soliciting materials
9:52am
8-K
IMNPQ
Immune Pharmaceuticals Inc
28 Nov 18
Immune Pharmaceuticals and Vector Therapeutics Sign Option Agreement for Worldwide CepleneĀ® Rights
5:14pm
8-K
IMNPQ
Immune Pharmaceuticals Inc
26 Nov 18
Triggering Events That Accelerate or Increase a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement
5:05pm
S-1
IMNPQ
Immune Pharmaceuticals Inc
IPO registration
21 Nov 18
4:05pm
3
John P Clark
20 Nov 18
IMMUNE PHARMACEUTICALS / John P Clark ownership change
9:57am
10-Q
2018 Q3
IMNPQ
Immune Pharmaceuticals Inc
Quarterly report
14 Nov 18
4:20pm
DEF 14A
IMNPQ
Immune Pharmaceuticals Inc
Definitive proxy
8 Nov 18
4:15pm